Skip to Content

BlackRock Advantage International Inv C BROCX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 18.39  /  +1.10 %
  • Total Assets 1.8 Bil
  • Adj. Expense Ratio
    1.500%
  • Expense Ratio 1.500%
  • Distribution Fee Level Low
  • Share Class Type Level Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 1.98%
  • Turnover 128%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0

Morningstar’s Analysis BROCX

Will BROCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin BlackRock Advantage International Inv C's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BROCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 22.6
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.64 62.7 Mil
Healthcare

ASML Holding NV

3.47 59.7 Mil
Technology

BlackRock Liquidity T-Fund Instl

2.37 40.7 Mil
Cash and Equivalents

Novartis AG Registered Shares

2.35 40.4 Mil
Healthcare

SAP SE

2.33 40.1 Mil
Technology

BHP Group Ltd

1.95 33.5 Mil
Basic Materials

Siemens AG

1.93 33.2 Mil
Industrials

Shell PLC

1.90 32.7 Mil
Energy

Tokyo Electron Ltd

1.69 29.2 Mil
Technology

Allianz SE

1.69 29.1 Mil
Financial Services